DK446179A - Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer - Google Patents

Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer

Info

Publication number
DK446179A
DK446179A DK446179A DK446179A DK446179A DK 446179 A DK446179 A DK 446179A DK 446179 A DK446179 A DK 446179A DK 446179 A DK446179 A DK 446179A DK 446179 A DK446179 A DK 446179A
Authority
DK
Denmark
Prior art keywords
carbadethyape
procedure
preparing substituted
carboxyl acids
carboxyl
Prior art date
Application number
DK446179A
Other languages
English (en)
Inventor
B G Christensen
D H Shih
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/954,273 external-priority patent/US4208422A/en
Priority claimed from US05/954,272 external-priority patent/US4232036A/en
Priority claimed from US05/954,270 external-priority patent/US4218462A/en
Priority claimed from US05/954,274 external-priority patent/US4206219A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK446179A publication Critical patent/DK446179A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
DK446179A 1978-10-24 1979-10-23 Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer DK446179A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US05/954,273 US4208422A (en) 1978-10-24 1978-10-24 1-Substituted-pen-2-em-3-carboxylic acids
US05/954,272 US4232036A (en) 1978-10-24 1978-10-24 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US05/954,270 US4218462A (en) 1978-10-24 1978-10-24 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US05/954,274 US4206219A (en) 1978-10-24 1978-10-24 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid

Publications (1)

Publication Number Publication Date
DK446179A true DK446179A (da) 1980-05-29

Family

ID=27506031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446179A DK446179A (da) 1978-10-24 1979-10-23 Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer

Country Status (4)

Country Link
EP (1) EP0010317B1 (da)
DE (1) DE2966497D1 (da)
DK (1) DK446179A (da)
IE (1) IE51861B1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR72296B (da) * 1979-12-03 1983-10-18 Merck & Co Inc
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids
WO1982000291A1 (en) * 1980-07-24 1982-02-04 Takeda Chemical Industries Ltd Carba-2-penem compounds and process for preparing same
DK329381A (da) * 1980-07-24 1982-01-25 Takeda Chemical Industries Ltd Fremgangsmaade til frmstilling af 1,1-disubstitueret carba-z -penem samt salte og estere deraf
WO1982003218A1 (fr) * 1981-03-19 1982-09-30 Takeda Chemical Industries Ltd Composes de carba-2-peneme et procede de preparation
ZA821361B (en) * 1981-03-04 1983-01-26 Beecham Group Plc Beta-lactam antibiotics,their preparation and use
ES8404184A1 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
EP0113101A1 (en) * 1982-12-30 1984-07-11 Merck & Co. Inc. 6-(1-Hydroxyethyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
US4696923A (en) * 1984-04-23 1987-09-29 Merck & Co., Inc. 6-[1-hydroxyethyl]-2-SR8 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acids
CA1281720C (en) * 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
US5310897A (en) * 1984-12-27 1994-05-10 Sumitomo Pharmaceuticals Co., Ltd. Beta-lactams and their production
EP0192171B1 (en) * 1985-02-19 1991-04-17 Merck & Co. Inc. Process for chiral synthesis of 1-bêta-methyl-carbapenem intermediates
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US5075436A (en) * 1986-01-08 1991-12-24 Merck & Co., Inc. Chiral 1-β-methyl-carbapenem intermediates
WO1988001619A1 (en) * 1986-08-29 1988-03-10 Sumitomo Pharmaceuticals Company, Limited 1'-methyl-beta-lactam compounds and their production
GB8804058D0 (en) * 1988-02-22 1988-03-23 Fujisawa Pharmaceutical Co 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
US5286721A (en) * 1990-10-15 1994-02-15 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
EP0684249B1 (en) * 1993-03-12 2003-02-19 Takasago International Corporation Phosphine compounds, complexes containing the phosphine compounds as ligands, and process for producing optically active aldehydes using the phosphine compounds or complexes
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
EP0704446A4 (en) * 1993-06-16 1996-06-12 Sumitomo Pharma NOVEL BETA-LACTAM COMPOUND AND PROCESS FOR PRODUCING THE SAME
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US5688786A (en) * 1994-04-01 1997-11-18 Microcide Pharmaceuticals, Inc. β-lactam antibiotics
WO1996038450A1 (en) * 1995-05-31 1996-12-05 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
JPH1077285A (ja) 1996-09-04 1998-03-24 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584762A (en) * 1977-04-01 1981-02-18 Beecham Group Ltd Azabicycloheptenes
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
SE7805032L (sv) * 1978-05-03 1979-11-03 Merck & Co Inc Karboxylsyror och derivat derav

Also Published As

Publication number Publication date
EP0010317B1 (en) 1983-12-21
EP0010317A1 (en) 1980-04-30
DE2966497D1 (en) 1984-01-26
IE792027L (en) 1980-04-24
IE51861B1 (en) 1987-04-15

Similar Documents

Publication Publication Date Title
DK446179A (da) Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK43279A (da) Fremgangsmaade til fremstilling af 2-penem-3-carboxylsyreforbindelser
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK364579A (da) Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK165687C (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK150479C (da) Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK149473C (da) Fremgangsmaade til fremstilling af aminomethan-phosphonsyrer
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK73379A (da) Fremgangsmaade til fremstilling af halogensubstituerede mercaptoacylaminsyrer
DK160485C (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK233379A (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK196579A (da) Fremgangsmaade til fremstilling af substituerede dibenzylethere
DK127179A (da) Fremgangsmaade til fremstilling af monokaryoner
DK444279A (da) Fremgangsmaade til fremstilling af 6-hydroxymethyl-2-(beta-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylsyre
DK60081A (da) Fremgangsmaade til fremstilling af diphenylethercarboxylsyrer
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK12879A (da) R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate
DK12379A (da) Fremgangsmaade til fremstilling af cysteinholdige peptider
DK277379A (da) Fremgangsmaade til fremstilling af acylaminomethanphosphonsyrer
DK260079A (da) Fremgangsmaade til fremstilling af phenoxyalkylamid-derivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment